Company news
Iridex Corporation (NASDAQ:IRIX) news
Iridex Corporation news releases on 6ix. Latest, Oct 5, 2026: Iridex Completes Relocation of Manufacturing Facility to San Jose, California
Press releases & updates
Iridex Completes Relocation of Manufacturing Facility to San Jose, California
October 4, 2026
Iridex Completes Relocation of Manufacturing Facility to San Jose, California
October 5, 2026
Iridex Reports Second Quarter 2026 Financial Results
August 18, 2026
Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026
August 4, 2026
Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering
July 20, 2026
Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference
June 9, 2026
Iridex Reports First Quarter 2026 Financial Results
May 18, 2026
Iridex to Report First Quarter 2026 Financial Results on May 19, 2026
May 5, 2026
Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology
April 6, 2026
Iridex Reports Fourth Quarter and Full Year 2025 Financial Results
March 25, 2026
Iridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026
March 12, 2026
Iridex Announces Plans to Relocate Headquarters
February 2, 2026
Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025
January 12, 2026
Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse® Technology in Glaucoma Management
December 11, 2025
Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse® Technology and Continuous-Wave Laser for Glaucoma Treatment
December 8, 2025
Iridex to Present at the Sidoti Year-End Virtual Investor Conference
December 5, 2025
Iridex Reports Third Quarter 2025 Financial Results
November 11, 2025
Iridex to Report Third Quarter 2025 Financial Results on November 11, 2025
October 28, 2025
Iridex Corporation Receives Formal Notification of Nasdaq Listing Compliance
September 9, 2025
Iridex Reports Second Quarter 2025 Financial Results
August 12, 2025
Iridex to Report Second Quarter 2025 Financial Results on August 12, 2025
July 29, 2025
Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse® Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema
June 24, 2025
Iridex Reports First Quarter 2025 Financial Results
May 13, 2025
Iridex to Report First Quarter 2025 Financial Results on May 13, 2025
April 30, 2025
Iridex Announces Preliminary Operational and Financial Results for the First Quarter 2025
April 14, 2025
Iridex to Host Strategic Vision Call on April 16, 2025
April 9, 2025
Iridex Reports Fourth Quarter and Full Year 2024 Financial Results
March 27, 2025
Iridex Announces Strategic Investment in the Company
March 19, 2025
Iridex Comments on Recent Stock Price Volatility
March 14, 2025
Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025
March 13, 2025
Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2024
January 13, 2025
Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management
December 17, 2024
Iridex Reports Third Quarter 2024 Financial Results
November 11, 2024
Iridex Appoints Patrick Mercer as Chief Executive Officer
October 2, 2024
Iridex Reports Second Quarter 2024 Financial Results
August 7, 2024
Iridex Announces Convertible Note Financing
August 4, 2024
Iridex Reports First Quarter 2024 Financial Results
May 13, 2024
Iridex to Report First Quarter 2024 Financial Results on May 14, 2024
May 7, 2024
Iridex Reports Fourth Quarter and Full Year 2023 Financial Results
March 25, 2024
Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024
March 19, 2024
Iridex Corporation Receives European Patent on MicroPulse Technology
February 5, 2024
Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust
January 23, 2024
Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma
January 10, 2024
Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation
November 26, 2023
Iridex Reports Third Quarter 2023 Financial Results and Business Update
November 13, 2023
Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023
November 12, 2023
Iridex to Report Third Quarter Financial Results on November 14, 2023
October 25, 2023
Iridex Announces Strategic Review to Unlock Shareholder Value
August 28, 2023
Iridex Reports Second Quarter 2023 Financial Results
August 9, 2023
Iridex to Report Second Quarter Financial Results on August 10, 2023
July 26, 2023